Immunotherapy firm, Genelux Corporation, has entered a licensing agreement with ELIAS Animal Health for its V-VET1, a vaccinia viral strain. The clinical stage product is intended to replicate in...
Nutritional company, Ultimate Pet Nutrition, has begun a 3-year sponsorship with nonprofit, Pets for Vets. The collaboration will allow for pets currently living in shelters to be matched with...
Mortality rates from Ebola outbreaks can be as high as 90%, according to the Centers for Disease Control and Prevention, and 55 people died in the most recent outbreak in Uganda in 2022.
In financial markets, the butterfly effect is not uncommon—a phenomenon where small changes in conditions can lead to significant long-term variations in a system's behavior.
Firm integrates scientific knowledge and regulatory expertise to offer comprehensive legal solutions and scientific guidance to life science companies.
Rio Tinto has committed $16 million to the Makira Natural Park REDD+1 Project in northern Madagascar, through a new partnership with the Wildlife Conservation Society (WCS) and Everland. This...
Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global public health and zoonosis concerns, presented new data at the Union World Conference on...
The American College of Veterinary Internal Medicine (ACVIM) is excited to announce a new endorsement partnership with IDEXX Laboratories, Inc., of complimentary resident-focused educational...
Non-steroidal anti-inflammatory drugs (NSAIDs) are often used as part of a multi-modal approach to manage chronic pain in cats, but minimizing adverse effects is necessary.
The Belle Époque was a historical period characterized by economic growth, technological and scientific advancements, and significant improvements in living conditions, particularly for the...
The Human Animal Bond Research Institute (HABRI) and MetLife Pet Insurance Solutions LLC (“MetLife Pet”), one of the world’s leading financial services companies, today announced a...
The purpose of this study was to assess sedation, emesis and cardiovascular effects of dexmedetomidine alone or combined with acepromazine in healthy cats.
Immunis, Inc., a clinical-stage biotech developing novel secretomes for age-related diseases and immune dysfunction, has initiated non-terminal safety studies with VetBio Partners, LLC for canine...
.jpg)
